FACE IPF
HEAD ON
and modify disease progression by slowing lung function decline
The Threat of Pulmonary Fibrosis Across A range of ILDs
23/01/2026 | Author: Boehringer Ingelheim
Document ID: PC-KW-100823 | Expiry Date: 01/18/2028
RELATED CONTENT
PDF
How to identify patients with RA-ILD who can benefit from OFEV
PC-KW-100729 (
)
PDF
The Need to Act in the Face of Progression
PC-KW-100734 (
)
PDF
Safety Profile of OFEV
PC-SA-102973 (
)
PDF
How to understand and manage limited cutaneous SSc-ILD
PC-SA-102972 (
)